BE
BE · BE · BE-AMP-SAM535066-00
Imbruvica 140 mg
ATC L01XE27
Last synced from FAMHP / AFMPS (Belgium) on
Identification
ManufacturerJanssen-Cilag International
CountryBE (BE)
ATC codeL01XE27
Dispensing—
ReimbursedNo
SourceFAMHP / AFMPS (Belgium)
Last synced6/13/2026
Packs · 2
- be_apb7727084
- be_apb3946753
Annotations
No annotations yet.
Raw payload (JSON)
{
"form": "Film-coated tablet",
"source": "afmps",
"status": "AUTHORIZED",
"name_en": "Imbruvica 140 mg",
"name_fr": "Imbruvica 140 mg",
"name_nl": "Imbruvica 140 mg",
"amp_code": "SAM535066-00",
"strengths": [
"140.0000",
"140.0000"
],
"pack_count": 3,
"substances": [
"Ibrutinib"
],
"medicine_type": "ALLOPATHIC",
"atc_description": "Ibrutinib",
"authorisation_numbers": [
"EU/1/14/945/003",
"EU/1/14/945/007",
"EU/1/14/945/008"
]
}Related drugs
Other records sharing ATC code L01XE27.
- IEIMBRUVICA 140 mg film-coated tabletsJanssen-Cilag International NV
- IEIMBRUVICA 140 mg hard capsulesJanssen-Cilag International NV
- BEImbruvica 280 mgJanssen-Cilag International
- IEIMBRUVICA 280 mg film-coated tabletsJanssen-Cilag International NV
- IEIMBRUVICA 420 mg film-coated tabletsJanssen-Cilag International NV
- IEIMBRUVICA 560 mg film-coated tabletsJanssen-Cilag International NV
Access this data programmatically
Query Imbruvica 140 mg and 610,000+ other drug records through a single REST API — with a last_synced_at provenance stamp on every response. Free tier includes 100 requests/day.